Please complete the CAPTCHA to continue
@bms.com
✓
3 phones found area 303 and 805
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Ryan Soderquist is listed as Senior Director, CMC Team Leader, BMS at Bristol Myers Squibb, based in Greater Philadelphia, United States. AeroLeads shows a work email signal at bms.com, phone signal with area code 303, 805, and a matched LinkedIn profile for Ryan Soderquist.
Ryan Soderquist previously worked as Senior Director, CMC Team Leader at Bristol Myers Squibb and Director, Global Vaccines and Biologics Commercialization-Project Leadership Group at Merck. Ryan Soderquist holds Doctor Of Philosophy - Phd, Chemical Engineering from University Of Colorado Boulder.
This section adds company-level context without repeating Ryan Soderquist's masked contact details.
AeroLeads found 1 current-domain work email signal for Ryan Soderquist. Compare company email patterns before reaching out.
Biochemical process engineer and scientist with significant accomplishments in downstream and upstream process development, analytical sciences and process engineering through multiple years of experience with Merck and Amgen.
Listed skills include Protein Purification, Protein Chemistry, Biotechnology, Purification, and 19 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Lawrence Township, Nj, Us
● Establishing first-time CMC strategies and workflows for an AAV gene therapy asset ● Advancing CMC strategies and deliverables for cell modification and DNA inhibitor products● Driving conversion of a commercial cell therapy product from an adherent to a suspension LVV manufacturing platform● Leading CMC team through a global submission package for label expansion of a commercial cell therapy product
● Directed development and commercialization teams (i.e. CMC team lead across DS, DP, Analytical, Regulatory, Marketing & Supply Chain) for two high-priority pipeline monoclonal antibody assets● Drove advancement of a single-use and continuous process (from a fed-batch process) for a commercial product
• Rapidly built a team of skilled upstream and downstream scientists (from 20 to 60 staff over a 12-month period)• Directed an accelerated cross-site process change for a commercial product to recover > $125 MM revenue annually• Led late-stage drug substance and drug product efforts and facilitated CDMO selection for an oncolytic virus asset
Thousand Oaks, Ca, Us
• Directed cross-site process development efforts to advance a novel oncology asset under accelerated timelines• Led groups implementing new technologies for continuous downstream and upstream processing, including AMBR and Tecan platforms with custom capabilities, to enable next generation processing paradigms • Managed and developed a team of six direct reports with responsibilities for commercial process development, process characterization and progressive manufacturing advancement for novel pipeline molecules• Facilitated development of a bioreactor-based process to replace roller bottle processing for a commercial product
Thousand Oaks, Ca, Us
• Managed and developed seven direct reports and a graduate intern with multiple interdisciplinary backgrounds• Directed external CMO activities for upstream and downstream commercial process development, process characterization, tech. transfer and scale-up as process team lead for a biosimilar mAb and an innovator mAb • Led efforts to relocate purification laboratories from Washington and Colorado to Cambridge, MA, and served as a change agent for staff movements into next generation office (a.k.a. open office) and laboratory environments
Thousand Oaks, Ca, Us
• Managed and developed four direct reports, who were responsible for various aspects of filtration, chromatography and viral clearance evaluations in a matrixed project and late stage process development setting • Authored and approved process characterization reports and regulatory filing sections under critical timelines as the downstream process characterization lead for Amgen’s first biosimilar molecule (FDA approved in Sep. 2016) • Championed efforts to find innovative approaches for the enrichment and isolation of host cell proteins and DNA to enable network-wide implementation of advanced process challenge studies and impurity characterization
Thousand Oaks, Ca, Us
• Managed a multi-disciplinary group of four direct reports and one indirect report in a regulated environment • Developed and implemented complex particle characterization methods for protein-silicone oil complexes, and procured state-of-the-art technology for the detection and quantification of protein particulates and aggregates• Led cross-site efforts to evaluate and demonstrate comparability and stability with respect to particle attributes for drug substance and drug product manufacturing site transfers and the introduction of new delivery devices • Developed and led strategies for in-line and at-line process analytical technology in commercial processes and implemented complex biochemical characterization methods for monoclonal antibodies and attenuated viruses• Completed Six Sigma Black Belt and Lean-DFSS certifications through Amgen and the Aveta business institute
● Led authoring of BLA sections for new virus-like particle purification and adjuvant manufacturing facilities ● Developed small scale purification models for all downstream unit operations of a key therapeutic protein asset
Boulder, Colorado, Us
• Advanced gene therapy administration in the central nervous system by microparticle encapsulation of plasmid DNA and polymer-protein bioconjugation (PEGylation) strategies for enhanced spinal delivery and distribution • Developed in vitro bioassays, conducted institutionally approved in vivo animal testing, and assessed in vivo drug distribution profiles with immunohistochemistry and confocal fluorescence microscopy• Conducted RT-PCR, ELISA, Western Blotting, Mass Spec and HPLC for in vitro and in vivo sample analysis
Thousand Oaks, Ca, Us
• Developed a new Micro-Flow Imaging (MFI) method and technology for sub-visible particle characterization• Prepared technical communications and trained personnel from other corporate sites in new methodologies• Completed a peer-reviewed method development report for multi-site method incorporation
Pullman/Spokane/Tri-Cities/Vancouver/Everett/Global, Washington, Us
• Developed methods to enhance recombinant protein production from transgenic plant cells• Maintained sensitive plant cell suspensions, quantified antibody titers by ELISA, performed restriction enzyme analysis, PCR amplification, site-directed mutagenesis, and gel electrophoresis• Completed extensive hands-on protein biotechnology training through interdisciplinary laboratory rotations in chemical engineering, biochemistry and molecular biology laboratories* Completed extensive hands-on protein biotechnology training through interdisciplinary laboratory rotations in chemical engineering, biochemistry and molecular biology laboratories
Logan, Utah, Us
• Conducted pilot-scale 10 and 100 L fermentations and harvests for external clients • Optimized tangential flow filtration and FPLC methods for advanced protein purification protocols• Developed training protocols in Fermentation, Microbial Scale-up and Protein Purification for industrial clients
Logan, Utah, Us
* Designed and built a nutrient-mist bioreactor for the cultivation of plant organ cultures* Developed and implemented tissue culture protocols for Ginkgo Biloba explants* Organized materials for academic and research purposes
Quick answers generated from the profile data available on this page.
Ryan Soderquist works for Bristol Myers Squibb.
Ryan Soderquist is listed as Senior Director, CMC Team Leader, BMS at Bristol Myers Squibb.
AeroLeads has found 1 work email signal at @bms.com for Ryan Soderquist at Bristol Myers Squibb.
AeroLeads has found 3 phone signal(s) with area code 303, 805 for Ryan Soderquist at Bristol Myers Squibb.
Ryan Soderquist is based in Greater Philadelphia, United States while working with Bristol Myers Squibb.
Ryan Soderquist has worked for Bristol Myers Squibb, Merck, Amgen, University Of Colorado At Boulder, and Washington State University.
You can use AeroLeads to view verified contact signals for Ryan Soderquist at Bristol Myers Squibb, including work email, phone, and LinkedIn data when available.
Ryan Soderquist holds Doctor Of Philosophy - Phd, Chemical Engineering from University Of Colorado Boulder.
Ryan Soderquist is listed with skills including Protein Purification, Protein Chemistry, Biotechnology, Purification, Hplc, Elisa, Western Blotting, and Gel Electrophoresis.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts